myeloid leukemia (AML) and found leukemic DNA methylation patterning is primarily driven
by nonpromoter regulatory elements and CpG shores. Enhancers displayed stronger
differential methylation than promoters, consisting predominantly of hypomethylation. AMLs
with dominant hypermethylation featured greater epigenetic disruption of promoters,
whereas those with dominant hypomethylation displayed greater disruption of distal and …